Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of glp-1 capsule in China. Welcome to wholesale bulk high quality glp-1 capsule for sale here from our factory. Good service and reasonable price are available.
GLP-1 Capsule is an intestinal insulinotropic hormone secreted by intestinal L cells, whose core function is to regulate energy metabolism through a "glucose dependent" mechanism. The capsule contains artificially synthesized GLP-1 receptor agonists (such as oral formulations of semaglutide and liraglutide), which activate the systemic GLP-1 receptors by simulating the action of natural GLP-1, achieving blood glucose control, appetite suppression, and energy consumption optimization. Some capsules are extracted from plant extracts such as IGOB131 ®, Cinnamaldehyde or probiotic ingredients (such as strains containing P9 protein) stimulate intestinal L cells to secrete more endogenous GLP-1, forming an "autologous hormone regulation cycle" and enhancing the sustainability of metabolic regulation. The core pathology of type 2 diabetes is insulin resistance and beta cell failure, which leads to imbalance of energy distribution: reduced glucose uptake by muscle and adipose tissue, increased gluconeogenesis in liver, and increased glucose and free fatty acid (FFA) levels in blood. GLP-1 receptor agonists promote insulin synthesis through the cAMP PKA pathway, while inhibiting beta cell apoptosis. They also reduce hepatic glucose output by decreasing hepatic FFA uptake and the expression of key gluconeogenesis enzymes such as PEPCK and G6Pase, while promoting hepatic sensitivity to insulin, transforming the liver from an "energy output organ" to an "energy storage organ". By activating the AMPK pathway, they promote glucose uptake and glycogen synthesis in muscle tissue, increase mitochondrial oxidative phosphorylation (OXPHOS) efficiency, reduce lactate production, and achieve "maximum energy utilization".
|
|
|
GLP-1 COA
adverse reaction
GLP-1 Capsule (glucagon like peptide-1) receptor agonists play an important role in the treatment of diabetes and obesity, and their capsule formulations are widely concerned by virtue of oral convenience. However, like all drugs, GLP-1 capsules may also trigger a series of adverse reactions while exerting therapeutic effects.
gastrointestinal reaction
Gastrointestinal reactions are the most common adverse reactions of GLP-1 capsules, and their mechanism of occurrence is closely related to the widespread distribution of GLP-1 receptors in the gastrointestinal tract. GLP-1 receptor agonists act by binding to GLP-1 receptors in the gastrointestinal tract, delaying gastric emptying, increasing satiety, and reducing food intake. However, this process may also cause a series of gastrointestinal discomfort symptoms.
Nausea: Nausea is one of the most common gastrointestinal reactions in the early stages of GLP-1 capsule treatment. Its incidence is relatively high, especially in the early stages of medication, and some patients may experience mild to moderate nausea due to the high sensitivity of the gastrointestinal tract to drugs. Nausea symptoms usually appear within hours to days after medication, and as the medication time prolongs, most patients' nausea symptoms will gradually alleviate or disappear. However, for a small number of patients, nausea symptoms may persist and even affect their daily life and medication adherence.
Vomiting: Vomiting is a further development of nausea, and when nausea symptoms are more severe, patients may experience vomiting. The occurrence of vomiting not only brings physical discomfort to patients, but may also lead to serious consequences such as electrolyte imbalance and dehydration. Therefore, patients who experience vomiting symptoms should seek medical attention promptly, assess their condition, and take appropriate treatment measures.
Dysdigestion: Dysdigestion is characterized by discomfort in the upper abdomen, a feeling of fullness, belching, and other symptoms. GLP-1 capsules may cause indigestion by affecting gastrointestinal motility and secretion of digestive fluids, leading to poor food digestion and absorption. Symptoms of indigestion usually appear in the early stages of medication, and with the prolongation of medication time, most patients' symptoms will gradually improve.
Abdominal pain: Some patients may experience abdominal pain symptoms during the use of GLP-1 capsules. Abdominal pain may manifest in different forms such as dull pain, bloating, or cramping, and its mechanism of occurrence may be related to the effect of drugs on gastrointestinal smooth muscle. Abdominal pain symptoms are usually mild, but a few patients may experience severe abdominal pain and need to seek medical attention promptly to investigate other causes.
Preventive and treatment measures:
Starting from a small dose and gradually increasing the dose
By gradually increasing the drug dose, the gastrointestinal tract gradually adapts to the effects of the drug, thereby reducing the incidence and severity of gastrointestinal reactions.
Adjusting dietary structure
It is recommended that patients eat easily digestible foods and avoid greasy, spicy, and irritating foods to reduce irritation to the gastrointestinal tract.
Split eating
Changing from three meals a day to multiple meals with less can help reduce the burden on the gastrointestinal tract and alleviate gastrointestinal reactions.
Symptomatic treatment
For patients with severe gastrointestinal reactions, antiemetic and antidiarrheal drugs can be used under the guidance of a doctor for symptomatic treatment.
Metabolism and endocrine response
GLP-1 capsule, as hypoglycemic drugs, have metabolic and endocrine reactions mainly involving hypoglycemia and thyroid dysfunction.
Hypoglycemia: GLP-1 receptor agonists are blood glucose concentration dependent hypoglycemic drugs, and their hypoglycemic effects are closely related to the blood glucose concentration in the patient's body. When blood sugar decreases, the effect of GLP-1 receptor agonists will correspondingly weaken, so the risk of hypoglycemia is lower when using GLP-1 capsules alone. However, when GLP-1 capsules are used in combination with other hypoglycemic drugs such as insulin, sulfonylureas, etc., the risk of hypoglycemia may increase. Symptoms of hypoglycemia include palpitations, sweating, hand tremors, hunger, etc. In severe cases, coma or even life-threatening situations may occur.
Preventive and treatment measures:
Strengthen blood glucose monitoring:
During the use of GLP-1 capsules, especially when combined with other hypoglycemic drugs, blood glucose monitoring should be strengthened to promptly detect hypoglycemia and take corresponding measures.
Adjust medication dosage:
Based on blood glucose monitoring results, adjust medication dosage in a timely manner under the guidance of a doctor to avoid the occurrence of hypoglycemia.
Carry sugar cubes or sugary drinks with you
For patients who are prone to hypoglycemia, it is recommended to carry sugar cubes or sugary drinks with you to replenish sugar in a timely manner when symptoms of hypoglycemia occur.
Thyroid dysfunction: GLP-1 receptor agonists may have certain effects on thyroid function, especially the risk of medullary thyroid cancer. Research has shown that GLP-1 receptor agonists can promote the formation of cyclic adenosine monophosphate in thyroid C cells, increasing serum calcitonin synthesis and release, which may lead to the occurrence of thyroid C cell carcinoma. However, the causal relationship between GLP-1 receptor agonists and medullary thyroid cancer is not yet fully understood. For safety reasons, patients with a personal or family history of medullary thyroid cancer should use GLP-1 capsules with caution.
Preventive and treatment measures:
Detailed medical history inquiry
Before using GLP-1 capsules, doctors should inquire in detail about the patient's thyroid disease history and family history to assess the risk of medication use.
Regular monitoring of thyroid function
For patients using GLP-1 capsules, it is recommended to regularly monitor thyroid function indicators (such as serum calcitonin, thyroid ultrasound, etc.) to promptly detect thyroid dysfunction and take corresponding measures.
Cardiovascular reactions
GLP-1 capsules may have certain effects on the cardiovascular system, mainly manifested as increased heart rate and changes in blood pressure.
Heart rate increase: The use of GLP-1 receptor agonists can cause an increase in heart rate in patients, and the magnitude of the increase in heart rate is related to the duration of GLP-1 action. Short acting GLP-1 receptor agonists may cause a brief increase in heart rate, while some long-acting GLP-1 receptor agonists may cause a sustained increase in circadian heart rate. An increase in heart rate may lead to discomfort symptoms such as palpitations and chest tightness, which may increase the risk of cardiovascular events for patients with pre-existing cardiovascular diseases.
Preventive and treatment measures:
Monitoring heart rate changes: During the use of GLP-1 capsules, patients should regularly monitor heart rate changes, promptly detect heart rate abnormalities, and take corresponding measures.
Symptomatic treatment: For patients with significant increase in heart rate, appropriate use of heart rate regulating drugs (such as beta blockers) can be administered under the guidance of a doctor for symptomatic treatment.
Blood pressure changes: The effect of GLP-1 receptor agonists on blood pressure is still controversial. Some studies suggest that GLP-1 receptor agonists may have a mild antihypertensive effect, while others have not found a significant impact on blood pressure. However, for patients with pre-existing hypertension, it is still necessary to closely monitor blood pressure changes when using GLP-1 capsules to avoid excessive blood pressure fluctuations that may cause cardiovascular events.
Preventive and treatment measures:
Regular monitoring of blood pressure: During the use of GLP-1 capsules, patients should regularly monitor blood pressure changes, promptly detect blood pressure abnormalities, and take corresponding measures.
Adjusting the dosage of antihypertensive drugs: For patients with pre-existing hypertension, it may be necessary to adjust the dosage of antihypertensive drugs in a timely manner under the guidance of a doctor based on blood pressure monitoring results when using GLP-1 capsules.
Neurological response
GLP-1 capsules may have certain effects on the nervous system, mainly manifested as symptoms such as headache and dizziness. These symptoms are usually mild, but a few patients may experience severe headaches or dizziness, affecting their daily life and work.
Preventive and treatment measures:
Pay attention to rest
During the use of GLP-1 capsule, patients should pay attention to rest, avoid overwork and mental stress, in order to reduce the occurrence of neurological reactions.
Symptomatic treatment
For patients with severe headaches or dizziness, painkillers or anti dizziness drugs can be used under the guidance of a doctor for symptomatic treatment.
Hot Tags: glp-1 capsule, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale